Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products
Wojciech Jankowski, Yara Park, Joseph McGill, Eugene Maraskovsky, Marco Hofmann, Vincent P Diego, Bernadette W Luu, Tom E Howard, Roberta Kellerman, Nigel S Key, Zuben E Sauna
Blood Advances | AMER SOC HEMATOLOGY | Published : 2019
Awarded by National Institutes of Health, National Institute of General Medical Sciences grant
Research conducted in the laboratory of Z.E.S. was supported by US Food and Drug Administration intramural grants from the Chief Scientist's Challenge Grant and the Critical Path Initiative. This project was supported in part by an appointment of J.M. to the Research Participation Program at the Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the US Food and Drug Administration. Research conducted in the laboratory of T.E.H. was supported in part by an investigator-initiated grant from CSL Behring to Haplomics Biotechnology, and relied on the use of University of Texas Rio Grande Valley facilities constructed with the support of National Institutes of Health, National Institute of General Medical Sciences grant C06 RR020537.